Brigid Lifesciences Pvt Ltd is an emerging leader in introducing state-of-the-art transplant technologies and point-of-care diagnostics that are clinically approved and on the verge of global commercialization. In the long term, Brigid aims to establish these breakthrough technologies as future gold standards either by replacing conventional protocols or integrating them as adjuncts to existing standards of care, in alignment with evolving clinical guidelines and best practices. The company is committed to integrating  innovations across every stage of the patient journey from early disease screening and accurate diagnosis to therapeutic intervention, surgical treatment, and transplant procedures, extending through to comprehensive post-operative care.